1-1 of 1 results for subject:Pfizer
Librarians' tools
- Search time
- 0.267 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, what assessment he has of made (a) the delays in administering the second doses of the Pfizer BioNTech and (b) the current status of supplies of the Pfizer BioNTech vaccine for the UK.
To ask the Secretary of State for Health and Social Care, what assessment he has of made (a) the delays in administering the second doses of the Pfizer BioNTech and (b) the current status of supplies of the Pfizer BioNTech vaccine for the UK.
There are no delays in administering the Pfizer vaccine. We have clear plans in place with Pfizer to ensure sufficient supply of the vaccine throughout 2021 and to prevent any shortages. There has been a regular and steady supply of vaccine doses arriving into the United Kingdom since early December and we have sufficient doses to maintain our vaccination programme as it continues to accelerate, working closely with Pfizer to ensure vaccines keep arriving into the UK.
We have sufficient vaccines available to administer second doses for Moderna, Pfizer and AstraZeneca, in line with the Medicines and Healthcare products Regulatory Agency and the Joint Committee on Vaccination and Immunization) guidance. The decision to offer second doses from 8 weeks for cohorts 1 – 9 factored in that there was sufficient supply to honour the plan. There are no known issues around availability to deliver the first or second dose plan for any vaccine.